Iridex introduces new research, showcases five events at the AGS Meeting

Iridex Corporation announced Part 2 of the evidence-based guidelines series for MicroPulse Transscleral Laser Therapy, TLT, has been published in Clinical Ophthalmology1 by the international consensus panel of ten glaucoma experts. The publication will be available at booth #5 at the 2023 meeting of the American Glaucoma Society, AGS, March 2 -5 in Austin, Texas. Consensus Panel Recommendations: Part 2 recommendations address anesthesia, surgical technique, post-operative care, expected outcomes, settings adjustment, and enhancements and retreatments. Part 1 of the consensus recommendations, published in 2021, focused on patient dosimetry and patient selection. "As physicians gathered further experience and conducted additional research on MicroPulse TLT, a better understanding of all aspects of the treatment helped improve the procedure and optimize outcomes," said Tomas Grippo, MD, co-chair of the International MicroPulse TLT Consensus Panel. "We are pleased to provide additional guidelines for a treatment we have found to be safe and effective for many types and severities of glaucoma."